UBS confirms its buy recommendation on Vivendi shares, with an unchanged target price of E14.70, following the announcement of the proposed demerger.

' Vivendi is studying the feasibility of demerging the company into several entities, each of which would be listed on the stock exchange', says the research consultancy.

The demerger project involves several entities structured around Canal+, Havas and an investment company including the stake in Lagardère.

Canal+, as well as Havas and Lagardère in particular, are currently experiencing strong dynamism, in an international context marked by numerous investment opportunities", said Vivendi in its press release, which aims to unleash their development potential.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.